Calton & Associates’s Prospect Capital PSEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-17,789
Closed -$46.1K – 474
2025
Q4
$46.1K Sell
17,789
-1,578
-8% -$4.21K 0.01% 441
2025
Q3
$53.3K Buy
+19,367
New +$57.9K 0.01% 420
2021
Q3
– Sell
-11,150
Closed -$94K – 430
2021
Q2
$94K Buy
11,150
+23
+0.2% +$192 0.02% 399
2021
Q1
$85K Buy
+11,127
New +$76.8K 0.02% 391
2018
Q1
– Sell
-2,500
Closed -$17K – 1041
2017
Q4
$17K Buy
+2,500
New +$16.3K ﹤0.01% 925

Other funds holding PSEC

Calton & Associates's PSEC Position: Q1 2026 in Review

Calton & Associates sold out of Prospect Capital (PSEC) in Q1 2026, closing a stake of 17,789 shares — an estimated $46.1K sold.

Calton & Associates first reported a position in PSEC in Q4 2017 and held it in 5 quarters. The position peaked at $94K in Q2 2021. 218 funds tracked by Wall St. Rank hold PSEC as of Q1 2026.

  • Calton & Associates reported no remaining Prospect Capital position as of Q1 2026 after selling out during the quarter.
  • Calton & Associates sold 17,789 Prospect Capital shares in Q1 2026, an estimated $46.1K.
  • Calton & Associates first reported a position in Prospect Capital in Q4 2017 and held it in 5 quarters.
  • Calton & Associates's Prospect Capital position peaked at $94K in Q2 2021.
  • 218 funds tracked by Wall St. Rank held Prospect Capital as of Q1 2026.

Based on Calton & Associates's 13F filing for Q1 2026, filed 13 May 2026.